Variant report
Variant | esv3435400 |
---|---|
Chromosome Location | chr3:145557562-145561260 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:145558279..145560976-chr3:145566285..145567836,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2055990 | chr3:145559802-145559803 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs186615746 | chr3:145559804-145559805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs144269264 | chr3:145559833-145559834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs201663972 | chr3:145559850-145559851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs190714224 | chr3:145559889-145559890 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs116397161 | chr3:145559899-145559900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs2055991 | chr3:145559923-145559924 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs551121502 | chr3:145559968-145559969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs148869746 | chr3:145560002-145560003 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs373489582 | chr3:145560004-145560005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs2055992 | chr3:145560005-145560006 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs2055993 | chr3:145560061-145560062 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs548399489 | chr3:145560070-145560071 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs560093054 | chr3:145560079-145560080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs375155419 | chr3:145560121-145560122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs566615465 | chr3:145560223-145560224 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs533530550 | chr3:145560239-145560240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs368184423 | chr3:145560245-145560246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs150233628 | chr3:145560256-145560257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs371835843 | chr3:145560261-145560262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs533852472 | chr3:145560305-145560306 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs558781780 | chr3:145560327-145560328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs570376031 | chr3:145560336-145560337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs537428250 | chr3:145560363-145560364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs561996926 | chr3:145560364-145560365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs545255887 | chr3:145560427-145560428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs563934733 | chr3:145560453-145560454 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs574186948 | chr3:145560491-145560492 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs3976500 | chr3:145560518-145560519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs151201294 | chr3:145560542-145560543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs187747005 | chr3:145560546-145560547 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs57827179 | chr3:145560585-145560586 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs140273766 | chr3:145560597-145560598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs565549208 | chr3:145560604-145560605 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs2055994 | chr3:145560623-145560624 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs77300301 | chr3:145560628-145560629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs563014284 | chr3:145560640-145560641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs74322504 | chr3:145560653-145560654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs398062892 | chr3:145560655-145560656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs530220665 | chr3:145560656-145560657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs374674161 | chr3:145560665-145560666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs548623252 | chr3:145560721-145560722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs190734136 | chr3:145560746-145560747 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs527452222 | chr3:145560760-145560761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs76668731 | chr3:145560774-145560775 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs570711650 | chr3:145560797-145560798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs537488733 | chr3:145560820-145560821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs555737909 | chr3:145560864-145560865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs73005683 | chr3:145560881-145560882 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs56394345 | chr3:145560902-145560903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Colorectal cancer | 18645599 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Blepharophimosis-ptosis-epicanthus inversus syndrome | 22067867 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Autism | 18923514 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Autism | 21956041 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Breast cancer | 16608533 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 21509527 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:145559800-145561600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |